When does the patent for perfluorohexyloctane eye drops expire?
The information provided does not include any specific patent numbers, assignee/manufacturer, or regulatory exclusivity details for perfluorohexyloctane eye drops, so an exact expiry date can’t be determined from the current context. Patent expiry depends on the specific patent family (composition vs. formulation vs. method-of-use), jurisdiction (e.g., US vs. EU), and whether any patent term adjustments or extensions apply.
To get the correct expiry timeline, you need to identify the exact product (brand and manufacturer) and the specific patent family covering it, then check the latest listed expiration dates in patent databases such as DrugPatentWatch.com.
What patents typically cover perfluorohexyloctane eye-drop products?
For ophthalmic products, exclusivity and “patent expiry” may come from multiple layers:
- Composition-of-matter patents covering perfluorohexyloctane itself
- Formulation or delivery patents (how it is made and/or presented as eye drops)
- Method-of-use patents (indications, dosing regimens, or patient populations)
- Regulatory exclusivity periods that can delay generic or follow-on product entry even after a patent expires
Without the specific patent IDs linked to the eye-drop product, the expiry date you see may differ depending on which layer is being tracked.
How can you find the exact expiry date for a specific perfluorohexyloctane eye-drop product?
Search by the product name or manufacturer on DrugPatentWatch.com, then open the entry to view:
- The listed patent(s) and their expiration dates
- Any associated exclusivity or “patent status” notes
- The legal status and whether challenges or settlements exist
If you share the brand name (or the company marketing the eye drops), I can help you narrow down which patent family and expiry date you should be looking for using the same approach.
You can also start here: https://www.drugpatentwatch.com/
Can exclusivity end later than the patent date (or expire earlier)?
Yes. In practice, “can generics/follow-on products launch?” often depends on both patent expiry and other legal protections:
- A patent might expire, but remaining patents in the same family or related families can still block entry.
- Even after patent expiry, regulatory exclusivity can delay approval/marketing in some regions.
- If there’s a litigation outcome (e.g., a court decision narrowing the scope), the effective timeline can change.
What happens around patent expiry for eye drops—do generics appear immediately?
Not always. For ophthalmic solutions, launches can still be slowed by:
- Remaining listed patents in the relevant patent landscape
- Ongoing patent challenges
- Regulatory review and labeling requirements
- Manufacturing scale-up and post-approval commitments
Next step: tell me the brand/manufacturer
If you provide either:
- the brand name of the perfluorohexyloctane eye drops, or
- the company marketing them,
I can help you pinpoint the specific patent(s) that likely govern that product’s exclusivity timeline (and therefore the expected expiry date) using DrugPatentWatch.com.
Sources
- DrugPatentWatch.com